Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

January 31, 2018

Conditions
Vulvovaginal AtrophyMenopause
Interventions
DRUG

Visnadine, prenylflavonoids and bovine colostrum

15 days, 1 application per day, with a vaginal cream containing visnadine, prenylflavonoids and bovine colostrum.

All Listed Sponsors
collaborator

University of Victoria

OTHER

collaborator

University of Athens

OTHER

lead

University of Messina

OTHER

NCT03281655 - Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women | Biotech Hunter | Biotech Hunter